Hinge Health (HNGE) CFO surrenders shares to cover RSU tax bill

Rhea-AI Filing Summary

Hinge Health, Inc. Chief Financial Officer James Budge reported a tax-related share disposition. On March 1, 2026, he relinquished 7,699 shares of Class A common stock at $42.76 per share, which were cancelled to cover federal and state tax withholding from vesting restricted stock units. After this exempt tax-withholding transaction, he beneficially owned 412,433 shares of Class A common stock.

Insider Trade Summary

Net Seller: 7,699 shares

Net Sell 1 txn

Insider Budge James

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Class A Common Stock	7,699	$42.76	$329K

Holdings After Transaction: Class A Common Stock — 412,433 shares (Direct)

Footnotes (1)

1. F1. Exempt transaction pursuant to Section 16b-3(e) - payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. All of the shares reported as disposed of in this Form 4 were relinquished by the Reporting Person and cancelled by the Issuer in exchange for the Issuer's agreement to pay federal and state tax withholding obligations of the Reporting Person resulting from the vesting of restricted stock units.

FAQ

What did Hinge Health (HNGE) CFO James Budge report in this Form 4?

Hinge Health CFO James Budge reported a tax-withholding disposition of 7,699 Class A shares. These shares were cancelled by the company to satisfy his federal and state tax obligations from vesting restricted stock units.

Was the HNGE CFO’s Form 4 transaction an open-market sale?

No, the transaction was not an open-market sale. The shares were relinquished and cancelled as an exempt tax-withholding transaction under Section 16b-3(e), covering taxes from restricted stock unit vesting.

How many Hinge Health (HNGE) shares did the CFO dispose of for taxes?

James Budge disposed of 7,699 shares of Hinge Health Class A common stock. The issuer cancelled these shares in exchange for paying his federal and state tax withholding obligations tied to restricted stock units.

At what price were the Hinge Health (HNGE) shares valued in the CFO’s tax transaction?

The tax-withholding disposition used a share price of $42.76 for 7,699 Class A shares. This price determined the value of stock surrendered to cover the CFO’s associated tax liabilities on vested restricted stock units.

How many Hinge Health (HNGE) shares does the CFO hold after this Form 4 transaction?

After the tax-withholding disposition, James Budge beneficially owned 412,433 shares of Hinge Health Class A common stock. This reflects his direct holdings following cancellation of 7,699 shares used to satisfy vesting-related tax obligations.

Why is the Hinge Health (HNGE) CFO’s Form 4 transaction classified as exempt?

The transaction is exempt under Section 16b-3(e) because it covers tax withholding by delivering or withholding securities. All disposed shares were cancelled in exchange for the issuer paying tax obligations from restricted stock unit vesting.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Accepted by SEC EDGAR 03/03/2026 - 05:25 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Budge James

(Last) (First) (Middle)

C/O HINGE HEALTH, INC.

455 MARKET STREET, SUITE 700

(Street)

SAN FRANCISCO CA 94105

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Hinge Health, Inc. [ HNGE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
03/01/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	03/01/2026		F(1)		7,699	D	$42.76	412,433	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Exempt transaction pursuant to Section 16b-3(e) - payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. All of the shares reported as disposed of in this Form 4 were relinquished by the Reporting Person and cancelled by the Issuer in exchange for the Issuer's agreement to pay federal and state tax withholding obligations of the Reporting Person resulting from the vesting of restricted stock units.

	/s/ James Budge	03/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.